A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
- Status
- COMPLETED
- Phase
- PHASE3
Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
- Status
- RECRUITING
- Phase
- PHASE4
Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3410738 in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Pirtobrutinib (LOXO-305) in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Effect of Food on Pirtobrutinib (LOXO-305) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Different Formulations of Midazolam in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Carbon-14-Labelled [14C] LOXO-305 (Pirtobrutinib) in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Relative Bioavailability Study of LY3454738 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1